Hormone receptor (HR) status (ER and PgR) is one of the most deterministic factors while other prognostic, but not predictive factors routinely used to assess breast cancer risk including tumor size, axillary lymph node and distant metastatic status, can be used to determine both clinical and pathological stages [7]. This evidence concerns the gene ESR1 and breast carcinoma.